INSIGHTS: Thoughts That Move Markets and Medicine — Dive Into the Sen‑Jam Perspective.

Top Posts

Top View Of Female Hands Holding Cup Of Hot Tea Original 2740162 Min 1 1

Sen-Jam Pharmaceutical Files Groundbreaking Patent for Novel Therapeutic Approac...

HUNTINGTON, N.Y., Jan. 9, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical, a leader in innovative anti-inflammatory care, today announced the submission of a new patent application that introduces…
Read More
Mask Group (17)

Sen-Jam Pharmaceutical Announces Planned AI Initiative for Molecule Repurposing

HUNTINGTON, N.Y., Jan. 10, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical (“Sen-Jam”), a pioneer in innovative inflammatory care, today announced a planned new initiative for use of leading-edge AI tools…
Read More
Group 1000001075

A Global Voice on Hangover Science: Dr. Joris Verster Publishes New Paper on Alc...

Sen-Jam Pharmaceutical is proud to celebrate the recent publication of an insightful new paper by Dr. Joris C. Verster, one of our esteemed scientific advisors and a world-renowned expert in alcohol hangover research…
Read More

Latest Posts

Group 15235 1 1 (1)

The End of Sickcare: From the Inside Out: A Spotlight on Cellular Longevity at t...

There are rare moments when political urgency, scientific progress, and cultural appetite collide — creating the conditions for real transformation. This may be one of them. With skyrocketing healthcare costs…
Read More
Group 1000001206

Sen-Jam Pharmaceutical Joins Forces with The Global Passion Project for Transfor...

HUNTINGTON, N.Y., April 1, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical is proud to sponsor and participate in The Global Passion Project’s upcoming Healthcare Investor Summit, taking place…
Read More
Group 1000001207 (1)

Behind the Breakthrough: Strategic Insights from Sen-Jam’s Executive Leade...

In March 2025, Sen-Jam Pharmaceutical hosted a pivotal webinar in collaboration with Destum Partners, a premier strategic advisory firm known for driving success in biotech partnerships, licensing, and M&A…
Read More
Mask Group (20)

Patent Milestone and Stability Data Strengthen Licensing Value of SJP-002C

One year ago, we filed a provisional patent application for our Upper Respiratory Infection Therapeutic – SJP-002C, covering the novel manufacturing process for our dual-acting oral therapy…
Read More
Eid Ashley Lauren St John Portrait 1 1

Sen-Jam Pharmaceutical Welcomes Immunology and Infectious Disease Expert Dr. Ash...

HUNTINGTON, N.Y., March 11, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical is thrilled to announce the appointment of Dr. Ashley St. John, Ph.D., to its Scientific Advisory Board, further strengthening…
Read More
Compressed Mask Group 16

Sen-Jam Pharmaceutical Engages Destum Partners to Source Strategic Partnerships ...

HUNTINGTON, N.Y., Feb. 10, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical, a pioneering biotech company dedicated to innovative anti-inflammatory solutions, is pleased to announce its engagement…
Read More
SHOW MORE

Where the Next Spark Becomes Tomorrow’s Headline

 

Our newsroom of scientists, strategists, and culture-watchers tracks the earliest pulses in biology, policy, and public conversation—translating fresh data into actionable perspective before the rest of pharma blinks. Stay tuned, stay sharp, and stay upstream with us.

Subscribe for Fresh Signals
MEDIA INQUIRIES

Media Inquiry